Booster shot: FDA may soon OK Moderna booster shot at half-dose level

The U.S. Food and Drug Administration is on the verge of authorizing half-dose booster shots of the Moderna COVID-19 vaccine, according to Bloomberg News.

>> Read more trending news

The agency had been looking at the effects a third full dose of the vaccine would have in fighting the novel coronavirus but is now close to OK’ing a half dose booster shot, Bloomberg reported, citing people familiar with the matter.

A full dose of Moderna’s vaccine contains 100 micrograms of mRNA, according to the company.

Moderna Chief Executive Stéphane Bancel said in a statement earlier this month that recipients of a 50-microgram dose had robust antibody responses against the delta variant.

Moderna submitted an application to the FDA for authorization of a booster shot on Sept. 1.

Last week the FDA approved a request by Pfizer/BioNTech to allow those fully vaccinated with its vaccine to get a booster shot.

Centers for Disease Control and Prevention Director Dr. Rochelle Walensky, endorsed the CDC Advisory Committee on Immunization Practices’ recommendation of a booster shot of the Pfizer COVID-19 vaccine in certain populations and also recommended a booster dose for those in high risk occupational and institutional settings.

More than 68 million people are fully vaccinated with the Moderna vaccine, according to the CDC.

Comments on this article